RAB1A and posterior cortical atrophy: Collectively, these findings establish the RAB1A-EV secretion axis as a master regulator of bone metastatic niche formation, driving immunosuppression via myeloid expansion and B-cell dysfunction, while its therapeutic blockade offers a multifaceted strategy to disrupt the vicious cycle of PCa progression.